Literature DB >> 9269995

Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer.

J P Elo1, P Härkönen, A P Kyllönen, O Lukkarinen, M Poutanen, R Vihko, P Vihko.   

Abstract

Several studies have indicated that in prostate cancer, frequent aberrations take place in several genomic regions. In the present study, we have analyzed allelic losses in chromosome 16 region q in 50 prostate cancer specimens of various histological grades. The most frequently deleted region was located at 16q23-16q24.2 between loci D16S504 and D16S422. The highest percentage of loss of heterozygosity (LOH) at 16q was also found within this area at loci HSD17B2 and D16S422 located at 16q24.1-q24.2. The LOH at 16q24.1-q24.2 was significantly associated with clinically aggressive behavior of the disease, metastatic disease, and higher tumor grade. Of the metastatic diseases, 83% showed LOH, whereas only 40% of the nonmetastatic diseases were found to show it. Similarly, LOH was found in 76% of the clinically aggressive diseases and in 33% of the nonaggressive diseases. The data suggest that a potentially important gene associated with prostate cancer progression is located close to 16q24.1-q24.2.

Entities:  

Mesh:

Year:  1997        PMID: 9269995

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  A genome screen of multiplex sibships with prostate cancer.

Authors:  B K Suarez; J Lin; J K Burmester; K W Broman; J L Weber; T K Banerjee; K A Goddard; J S Witte; R C Elston; W J Catalona
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

2.  Genomewide scan for prostate cancer-aggressiveness loci.

Authors:  J S Witte; K A Goddard; D V Conti; R C Elston; J Lin; B K Suarez; K W Broman; J K Burmester; J L Weber; W J Catalona
Journal:  Am J Hum Genet       Date:  2000-05-24       Impact factor: 11.025

3.  Association of genetic polymorphisms in HSD17B1, HSD17B2 and SHBG genes with hepatocellular carcinoma risk.

Authors:  Lu Shun Zhang; Fang Yuan; Xuan Guan; Juan Li; Xin Lian Liu; Jing Sun; Bo Liu; Wei Ma; Feng Mei Deng
Journal:  Pathol Oncol Res       Date:  2014-02-22       Impact factor: 3.201

4.  Genetics of prostate cancer.

Authors:  Kai Qi Zhang; Sherry A Salzman; D J Reding; Brian K Suarez; William J Catalona; James K Burmester
Journal:  Clin Med Res       Date:  2003-01

5.  Alterations of the WNT7A gene in clear cell renal cell carcinomas.

Authors:  Aleksandr G Kondratov; Sergiy M Kvasha; Liubov A Stoliar; Alina M Romanenko; Yury M Zgonnyk; Vasily V Gordiyuk; Elena V Kashuba; Alla V Rynditch; Eugene R Zabarovsky; Vladimir I Kashuba
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

6.  Three independently deleted regions at chromosome arm 16q in human prostate cancer: allelic loss at 16q24.1-q24.2 is associated with aggressive behaviour of the disease, recurrent growth, poor differentiation of the tumour and poor prognosis for the patient.

Authors:  J P Elo; P Härkönen; A P Kyllönen; O Lukkarinen; P Vihko
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

7.  Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array.

Authors:  N Tørring; M Borre; K D Sørensen; C L Andersen; C Wiuf; T F Ørntoft
Journal:  Br J Cancer       Date:  2007-01-23       Impact factor: 7.640

8.  Chromosome band 16q24 is frequently deleted in human gastric cancer.

Authors:  Y Mori; M Matsunaga; T Abe; S Fukushige; K Miura; M Sunamura; K Shiiba; M Sato; T Nukiwa; A Horii
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

9.  17beta-Hydroxysteroid dehydrogenases involved in local oestrogen synthesis have prognostic significance in breast cancer.

Authors:  C Gunnarsson; E Hellqvist; O Stål
Journal:  Br J Cancer       Date:  2005-02-14       Impact factor: 7.640

Review 10.  Roles of autophagy induced by natural compounds in prostate cancer.

Authors:  V Naponelli; A Modernelli; S Bettuzzi; F Rizzi
Journal:  Biomed Res Int       Date:  2015-03-03       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.